We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

1 hedge funds and large institutions have $1K invested in Sophiris Bio, Inc. in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $1K → $1K ($0)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$1K – – –

SPHS Hedge Fund Activity: Q4 2021 in Review

1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2021, worth a combined $1K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SPHS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Sophiris Bio, Inc. (SPHS) as of Q4 2021, down from 2 in Q3 2021.
  • Funds reported $1K of Sophiris Bio, Inc. stock for Q4 2021, unchanged quarter-over-quarter.
  • 0 funds opened new Sophiris Bio, Inc. positions in Q4 2021 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q4 2021.